2012 (7)
Václav Špičák, Vít Petrů............................................................................237
PŘEHLEDNÉ ČLÁNKY
České stopy v alergologii
Václav Špičák.........................................................................................246
Imunologie aterosklerózy
Pavel Kraml...........................................................................................252
Resolviny, maresiny a 14, 21-dihydroxyDHA –
lipidové mediátory s protizánětovými a reparačními účinky
vzniklé přeměnou ω-3 nenasycených mastných kyselin
Drahomíra Holmannová, Martina Koláčková, Jan Krejsek............................262
Degradace alergenů členovců v prostředí člověka
Jan Hubert, Radek Klubal........................................................................266
FARMAKOTERAPIE, IMUNOTERAPIE
Imunomodulační účinky makrolidových antibiotik
Jana Zemánková, Ilja Stříž........................................................................271
DIAGNOSTIKA A LABORATORINÍ TECHNIKA
Kondenzát vydechovaného vzduchu –
neinvazivní metoda vyšetření zánětu dýchacích cest
Tatiana Gvozdiaková, František Kopřiva......................................................283
KASUISTIKY
Bulózní forma Henoch-Schönleinovy purpury
Tatiana Gvozdiaková, František Kopřiva,Martin Zápalka, Vladimír Mihál.........291
Očkování proti infekčním onemocněním a autoimunita
Náhodná koincidence či plod kauzality?
Eva Daňková.............................................................................................295
DISKUSNÍ FORUM
Jiří Novák...................................................................................................300
Radim Šrám; Miroslav Dostál.......................................................................301
CONTENTS
REVIEWS
Czech traces in allergology
Václav Špičák...........................................................................................246
Immunology of atherosclerosis
Pavel Kraml...............................................................................................252
Resolvins, maresins and 14, 21-dihydroxyDHA –
lipid mediators with antiinflammatory and reparation
activities derived by enzymatic conversion
from ω-3 polyunsaturated fatty acids
Drahomíra Holmannová, Martina Koláčková, Jan Krejsek................................262
The allergen degradation in human environment
Jan Hubert, Radek Klubal............................................................................266
FARMAKOTHERAPY, IMUNOTHERAPY
Immunomodulatory effects of macrolide antibiotics
Jana Zemánková, Ilja Stříž...........................................................................271
DIAGNOSTIC AND LABORATORY TECHNIQUE
Exhaled breath condensate - non-invasive method
for the examination of airway inflammation
Tatiana Gvozdiaková, František Kopřiva.........................................................283
CASE REPORT
Bullous form of Henoch-Schönlein purpura
Tatiana Gvozdiaková, František Kopřiva,
Martin Zápalka, Vladimír Mihál.....................................................................291
Vaccination against infectious diseases and autoimmunity.
Occasional coincidence or a consequence of causality?
Eva Daňková.............................................................................................295
DISCUSSION FORUM
Jiří Novák.................................................................................................300
Radim Šrám, Miroslav Dostál .................................................................... 301
Editorial
Vít Petrů, Kateřina Absolonová......................................................................................................1
Program......................................................................................................................................8
Úvodní přednášky
Budoucnost pediatrických alergologů?
Ulrich Wahn...............................................................................................................................14
Směrovaná nanoterapeutika a imunostimulace – jen experiment nebo nové možnosti?
Blanka Říhová.............................................................................................................................14
ILC-bunky –noví hráči na poli obranyschopnosti a imunopatológie
Milan Buc...................................................................................................................................15
ABSTRAKTA
1. Astma a respirační alergie........................................................................................................17
2. Potravinová alergie.................................................................................................................. 20
3. Imunointervence.......................................................................................................................22
4. Privátní praxe......................................................................................................................... 25
5. Imunodeficience.......................................................................................................................26
6. Regulace v imunitním systému..................................................................................................28
7. Autoprotilátky v patogenezi autoimunitních onemocnění...............................................................31
8. Imunopatologické stavy I. .........................................................................................................33
9. Aerobiologie, BHR....................................................................................................................36
10. Diagnostika v alergologii..........................................................................................................38
11. Anafylaxe, angioedém, lékové alergie........................................................................................40
12. Varia......................................................................................................................................44
13. Sekce sester..........................................................................................................................46
14. Laboratorní diagnostika........................................................................................................... 52
15. Imunopatologické stavy II. .......................................................................................................54
16. Sekce laborantů......................................................................................................................56
Editorial
Vít Petrů........................................................................................................................................ 1
Programme.................................................................................................................................... 8
Opening lectures
Future for Pediatric Allergists?
Ulrich Wahn .................................................................................................................................14
Targeted nanotherapeutics and immunostimulation – experiment only or a new strategy?
Blanka Říhová............................................................................................................................... 14
ILC – new players in the field of immune defence mechanisms and immunopathology
Milan Buc .....................................................................................................................................15
Abstracts
1. Asthma and respiratory allergies .................................................................................................17
2. Food allergy ............................................................................................................................. 20
3. Immuno-Intervention ...................................................................................................................22
4. Private practice.......................................................................................................................... 25
5. Immunodeficience ......................................................................................................................26
6. Regulation of the immune system ...............................................................................................28
7. Autoantibodies in the pathogenesis of autoimmune diseases ........................................................31
8. Immunopathological states I. ..................................................................................................... 33
9. Aerobiology, BHR ......................................................................................................................36
10. Diagnosis in allergology ............................................................................................................38
11. Anaphylaxis, angioedema, drug allergies ................................................................................... 40
12. Varia .......................................................................................................................................44
13. Nurses section .........................................................................................................................46
14. Laboratory diagnostics .............................................................................................................52
15. Immunopathological states II..................................................................................................... 54
16. Laboratory technical assistant section .......................................................................................56
Posters .........................................................................................................................................61
Původní práce
Výskyt astmatu a dalších respiračních onemocnění u školních dětí v Ostravě
Petr Pohunek .........................................................................................................................169
HLA-G polymorfizmus a asthma bronchiale
Vladimíra Ďurmanová, Martin Dzurilla, Mojmír Vrlík,
Magda Suchánková, Milan Buc, Mária Bucová ...........................................................................180
Funkční aktivita FcεRI receptoru u osob s protilátkovými deficity
Alexandra Lochmanová, Vítězslav Novák, Olga Škopková ...........................................................187
Přehledné články
Genetika systémových imunopatologických stavů
Dalibor Jílek ............................................................................................................................191
Těhotenství a regulační T-lymfocyty
Eva Mitášová, Jan Krejsek, Marian Kacerovský, Ctirad Andrýs ....................................................196
Poruchy funkce Toll-like receptorů u dětí s invazivní
pneumokokovou infekcí a herpetickými encefalitidami
Radek Špíšek, Petra Králíková .................................................................................................203
Farmakoterapie, imunoterapie
Specifická alergenová imunoterapie a léčba atopické dermatitidy
Jiřina Chládková ..................................................................................................................... 209
Polyalergie a polysenzitivita – je vhodná alergenová imunoterapie?
Martin Hrubiško, Václav Špičák .................................................................................................217
Diagnostické postupy u pacientů s alergií na včelí a vosí jed
Martina Vachová, Petr Panzner, Tomáš Vlas ..............................................................................223
diskusní forum .........................................................................................................................230
informace ................................................................................................................................231
CONTENTS
Editorial
Václav Špičák ..........................................................................................................................161
Original Papers
Bronchial asthma and other respiratory diseasesin school children in Ostrava
Petr Pohunek ...........................................................................................................................169
HLA-G polymorphism and bronchial asthma
Vladimíra Ďurmanová, Martin Dzurilla, Mojmír Vrlík,
Magda Suchánková, Milan Buc, Mária Bucová .............................................................................180
Functional activity of FcεRI receptor in patients with immunoglobulin deficiency
Alexandra Lochmanová, Vítězslav Novák, Olga Škopková .............................................................187
Reviews
Genetics of systemic immunopathologic conditions
Dalibor Jílek ..............................................................................................................................191
Pregnancy and regulatory T-lymphocytes
Eva Mitášová, Jan Krejsek, Marian Kacerovský, Ctirad Andrýs ......................................................196
Defects of Toll-like receptors function in children with
pneumococcal infections and herpetic encefalitis
Radek Špíšek, Petra Králíková ...................................................................................................203
Pharmacotherapy, Imunotherapy
Specific allergen immunotherapy and treatment of atopic dermatitis
Jiřina Chládková ....................................................................................................................... 209
Polyallergy and polysensitivity – is allergen immunotherapy appropriate?
Martin Hrubiško, Václav Špičák ..................................................................................................217
Diagnostic approaches in bee and wasp venom allergic patients
Martina Vachová, Petr Panzner, Tomáš Vlas ................................................................................223
discuss forum ...........................................................................................................................230
information ............................................................................................................................... 231
Asthma bronchiale u kojenců a batolat
Daniela Židová, Ilja Stříž, Petr Pohunek .....................................................................................45
Onemocnění dávivým kašlem je časté i v praxi klinického imunologa
Josef Richter, Romana Chrudimská, Ivana Stiborová,
Jitka Pohořská, Dalibor Jílek, Vlastimil Král ..............................................................................50
CONTENTS
Editorial
Václav Špičák ................................................................................................................................93
Alergie 2012
Jak se rozhodovat v éře medicíny založené na důkazech – jasná teorie, sporná praxe
Václav Špičák ...............................................................................................................................100
Jak a kdy ukončit dlouhodobou léčbu astmatu dospělých?
Viktor Kašák .................................................................................................................................102
Antileukotrieny v dlouhodobém nebo intermitentním podávání?
František Kopřiva ...........................................................................................................................108
Jak na kožní alergie? Hormonální, nehormonální léčba dle medicíny založené na důkazu
Alena Machovcová ..........................................................................................................................113
Jaroslav Šterzl 1925–2012
Václav Špičák ................................................................................................................................123
Účast slizničního imunitního systému a komensálních bakterií v alergii
Helena Tlaskalová-Hogenová, Jiří Městecký ......................................................................................124
Asociace haplotypů polymorfismů v STAT6 s hladinou IgE a rozdíl v četnosti těchto haplotypů
vzhledem k jejich rodičovském původu u dětí s asthma bronchiale
Marek Godava, František Kopřiva, Jana Böhmová, Radek Vodička,
Radek Vrtěl, Jana Cvanová, Ladislav Dušek, Jan Mužík ......................................................................134
Farmakoterapie, imunoterapie
Roztroušená skleróza – prevence infekcí varicella-zoster virem (VZV) před zahájením léčby fingolimodem
Vojtěch Thon ..................................................................................................................................140
Doporučení pro správné používání masti PROTOPIC (takrolimus) (0,03% a 0,1%) k minimalizaci rizika
Astellas Pharma Europe ..................................................................................................................143
Diagnostika
Kožní testy – základní diagnostický postup v alergologii
Vít Petrů .........................................................................................................................................145
Manózu vázající lektin a infekce v klinické praxi
Martin Hospodka .............................................................................................................................149
Postup pro vyšetřování ANCA
Ivo Lochman ....................................................................................................................................155
Informace .......................................................................................................................................157
CONTENTS
Editorial
Václav Špičák ..................................................................................................................................93
Allergy 2012
How to take a decision in the time of EBM – clear theory, disputable practice
Václav Špičák ................................................................................................................................100
How and when discontinued maintenance therapy of adult asthmatic patients?
Viktor Kašák ..................................................................................................................................102
Antileukotrienes on prolonged or intermittent dosage?
František Kopřiva ............................................................................................................................108
How to treat skin allergies according to evidence based medicine
Alena Machovcová ..........................................................................................................................113
Jaroslav Šterzl 1925–2012
Václav Špičák ................................................................................................................................123
Role of the mucosal immune system and commensal bacteria in allergy
Helena Tlaskalová-Hogenová, Jiří Městecký .......................................................................................124
Association of single nucleotides polymorphisms haplotypes
of STAT6 with total IgE level and difference in the haplotypes
frequency according to parental origin in asthma having children
Marek Godava, František Kopřiva, Jana Böhmová, Radek Vodička,
Radek Vrtěl, Jana Cvanová, Ladislav Dušek, Jan Mužík .....................................................................134
Pharmacotherapy, Imunotherapy
Multiple sclerosis - Prevention of varicella-zoster virus (VZV) infections before fingolimod treatment
Vojtěch Thon .................................................................................................................................140
How to use Protopic Ointment 0,03%, 0,1%
Astellas Pharma Europe .................................................................................................................143
Diagnostic
Skin tests – a basic diagnostic method in allergology
Vít Petrů ........................................................................................................................................145
Mannose-binding lectin and infection in practice
Martin Hospodka ............................................................................................................................149
Procedure for the investigation of ANCA
Ivo Lochman ..................................................................................................................................155
PŮVODNÍ PRÁCE
PŘEHLEDNÉ ČLÁNKY
FARMAKOTERAPIE, IMUNOTERAPIE
KASUISTIKY
KONFERENCE, KONGRESY
PŘEČETLI JSME ZA VÁS ............................................................. 85
INFORMACE ................................................................................ 87
ORIGINAL PAPERS
REVIEWS
FARMACOTHERAPY, IMMUNOTHERAPY
CASE REPORT
CONFERENCE, CONGRESSES
WE HAVE READ FOR YOU ........................................................ 85
INFORMATION ........................................................................... 87